Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register
暂无分享,去创建一个
M. Eadie | A. Hitchcock | J. Graham | F. Vajda | C. Lander | T. O'Brien | Mervyn Eadie | Terence O'Brien
[1] S. Kochen,et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.
[2] P. Sarma,et al. Teratogenicity of antiepileptic dual therapy , 2018, Neurology.
[3] A. Hitchcock,et al. Antiepileptic drugs, foetal malformations and spontaneous abortions , 2017, Acta neurologica Scandinavica.
[4] M. Eadie,et al. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations , 2016, Epilepsia.
[5] M. Eadie,et al. Is carbamazepine a human teratogen? , 2016, Journal of Clinical Neuroscience.
[6] G. Koren,et al. Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.
[7] J. Graham,et al. The teratogenicity of the newer antiepileptic drugs – an update , 2014, Acta neurologica Scandinavica.
[8] M. Eadie,et al. Prediction of the hazard of foetal malformation in pregnant women with epilepsy , 2014, Epilepsy Research.
[9] M. Eadie,et al. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero , 2013, Acta neurologica Scandinavica.
[10] T. O'Brien,et al. Dose dependence of fetal malformations associated with valproate , 2013, Neurology.
[11] B. Wlodarczyk,et al. Antiepileptic drugs and pregnancy outcomes , 2012, American journal of medical genetics. Part A.
[12] S. Hernández-Díaz,et al. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. , 2011, Archives of neurology.
[13] T. Tomson,et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.
[14] T. O'Brien,et al. The teratogenic risk of antiepileptic drug polytherapy , 2010, Epilepsia.
[15] S. B. Lucas,et al. Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study , 2010, Seizure.
[16] M. Martinez-frias,et al. TOPIRAMATE IN PREGNANCY: PRELIMINARY EXPERIENCE FROM THE UK EPILEPSY AND PREGNANCY REGISTER , 2009, Neurology.
[17] K. Meador,et al. Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts , 2008, Epilepsy Research.
[18] B. Irwin,et al. Topiramate in pregnancy , 2006, Neurology.
[19] B. Irwin,et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[20] M. Eadie,et al. Maternal valproate dosage and foetal malformations , 2005, Acta neurologica Scandinavica.
[21] T. O'Brien,et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy , 2004, Journal of clinical neuroscience.
[22] A. Ornoy,et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. , 2002, Reproductive toxicology.
[23] M. Riley,et al. Birth Defects in Victoria 1983–1998 , 2000 .
[24] A. Hofman,et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.
[25] K. Inanaga,et al. Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan , 1980, Epilepsia.